Caryophillan-2,6-beta-oxide

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 氧杂环己烷
• 英文名称: Caryophillan-2,6-beta-oxide
• 英文别名: 1,4,4,8-tetramethyl-12-oxatricyclo[6.3.1.02,5]dodecane
• 化学式: C₁₅H₂₆O
• 分子量: 222.37
• InChiKey: FMRYSKILCWLXDC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  16
• 可旋转键数：
  0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• Antitumor methods and compositions comprising sesquiterpene derivatives
  申请人：——

  公开号：US20040191342A1

  公开（公告）日：2004-09-30

  The present invention relates to novel antitumor compositions, the use of sesquiterpene derivatives as antitumor agents and to methods of treatment thereof. More precisely, The present invention relates to an antitumor composition comprising a therapeutically effective quantity of at least one sesquiterpene derivative in association with a pharmaceutically acceptable carrier.

  本发明涉及新型抗肿瘤组合物、倍半萜衍生物作为抗肿瘤剂的用途及其治疗方法。更确切地说，本发明涉及一种抗肿瘤组合物，该组合物包含治疗有效量的至少一种倍半萜衍生物与药学上可接受的载体。
• ANTITUMOR METHODS AND COMPOSITIONS COMPRISING SESQUITERPENE DERIVATIVES
  申请人：F.P.L. Pharma Inc.

  公开号：EP1372677A1

  公开（公告）日：2004-01-02
• [EN] ANTITUMOR METHODS AND COMPOSITIONS COMPRISING SESQUITERPENE DERIVATIVES<br/>[FR] PROCEDES ET COMPOSITIONS ANTI-TUMORALES COMPORTANT DES DERIVES SESQUITERPENIQUES
  申请人：F P L PHARMA INC

  公开号：WO2002078719A1

  公开（公告）日：2002-10-10

  The present invention relates to novel antitumor compositions, the use of sesquiterpene derivatives as antitumor agents and to methods of treatment thereof. More precisely, The present invention relates to an antitumor composition comprising a therapeutically effective quantity of at least one sesquiterpene derivative in association with a pharmaceutically acceptable carrier.